| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.41 | 0.008 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.37 | 0.01 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |